KORU Medical Systems, Inc. (KRMD)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 20M 40M 60M Q3 '21: 21.1M Q4 '21: 23.5M Q1 '22: 24.3M Q2 '22: 25.3M Q3 '22: 27M Q4 '22: 27.9M Q1 '23: 29M Q2 '23: 29.4M Q3 '23: 28.7M Q4 '23: 28.5M Q1 '24: 29.3M Q2 '24: 30.8M Q3 '24: 32M Q4 '24: 33.6M Q1 '25: 35.1M Q2 '25: 36.8M Q3 '25: 39.1M Q4 '25: 41.1M Q1 '26: 43.3M Q2 '26: 45.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 10M 20M 30M Q3 '21: 12.2M Q4 '21: 13.8M Q1 '22: 14.2M Q2 '22: 14.3M Q3 '22: 15.1M Q4 '22: 15.4M Q1 '23: 15.9M Q2 '23: 16.4M Q3 '23: 16.5M Q4 '23: 16.7M Q1 '24: 17.7M Q2 '24: 19.3M Q3 '24: 20.1M Q4 '24: 21.3M Q1 '25: 22.3M Q2 '25: 23.3M Q3 '25: 24.3M Q4 '25: 25.6M Q1 '26: 26.8M Q2 '26: 28.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-12M -8M -4M 0 4M 8M 12M Q3 '21: -6.1M Q4 '21: -7M Q1 '22: -7.9M Q2 '22: -10.2M Q3 '22: -10.4M Q4 '22: -10.8M Q1 '23: -10.7M Q2 '23: -10.3M Q3 '23: -10.6M Q4 '23: -10.3M Q1 '24: -9.2M Q2 '24: -7.1M Q3 '24: -7.1M Q4 '24: -6.4M Q1 '25: -5.7M Q2 '25: -4.9M Q3 '25: -4M Q4 '25: -3M Q1 '26: -2.6M Q2 '26: -1.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-15M -10M -5M 0 5M 10M 15M Q3 '21: -4.3M Q4 '21: -4.6M Q1 '22: -5.8M Q2 '22: -7.6M Q3 '22: -7.8M Q4 '22: -8.7M Q1 '23: -8.5M Q2 '23: -8.1M Q3 '23: -8.3M Q4 '23: -13.7M Q1 '24: -13.3M Q2 '24: -11.8M Q3 '24: -12M Q4 '24: -6.1M Q1 '25: -5.3M Q2 '25: -4.5M Q3 '25: -3.7M Q4 '25: -2.6M Q1 '26: -2.3M Q2 '26: -1.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 6M 12M 18M Q3 '21: 8.8M Q4 '21: 9.7M Q1 '22: 10.1M Q2 '22: 11M Q3 '22: 11.9M Q4 '22: 12.5M Q1 '23: 13.2M Q2 '23: 13M Q3 '23: 12.2M Q4 '23: 11.8M Q1 '24: 11.7M Q2 '24: 11.6M Q3 '24: 11.9M Q4 '24: 12.3M Q1 '25: 12.8M Q2 '25: 13.6M Q3 '25: 14.7M Q4 '25: 15.5M Q1 '26: 16.5M Q2 '26: 16.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-9M -6M -3M 0 3M 6M 9M Q4 '20: -743.3K Q1 '21: -3.5M Q2 '21: -6.2M Q3 '21: -5.3M Q4 '21: -4.3M Q1 '22: -3.5M Q2 '22: -6.2M Q3 '22: -7.5M Q4 '22: -5.4M Q1 '23: -8.3M Q2 '23: -5.6M Q3 '23: -4.7M Q4 '23: -4.9M Q1 '24: -578.7K Q2 '24: -413.4K Q3 '24: -162.5K Q4 '24: -319.7K Q1 '25: -210.5K Q2 '25: -682.1K Q3 '25: 307.3K Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

Free Cash Flow TTM

-12M -8M -4M 0 4M 8M 12M Q4 '20: -1.7M Q1 '21: -4.4M Q2 '21: -6.9M Q3 '21: -5.6M Q4 '21: -4.7M Q1 '22: -4.5M Q2 '22: -8.3M Q3 '22: -10M Q4 '22: -8.2M Q1 '23: -10.6M Q2 '23: -6.8M Q3 '23: -5.5M Q4 '23: -5.7M Q1 '24: -1.2M Q2 '24: -1.1M Q3 '24: -1.7M Q4 '24: -1.6M Q1 '25: -1.8M Q2 '25: -2.2M Q3 '25: -173.9K Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '20: 39.9M Q2 '20: 40.4M Q3 '20: 44.1M Q1 '21: 44M Q2 '21: 44.5M Q3 '21: 44.3M Q1 '22: 44.7M Q2 '22: 44.9M Q3 '22: 45M Q1 '23: 45.5M Q2 '23: 45.6M Q3 '23: 45.6M Q1 '24: 45.7M Q2 '24: 45.8M Q3 '24: 45.9M Q1 '25: 46M Q2 '25: 46.2M Q3 '25: 46.2M Q1 '26: 46.4M Q2 '26: 49.5M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.30 -0.20 -0.10 0.00 0.10 0.20 0.30 Q3 '21: -0.10 Q4 '21: -0.10 Q1 '22: -0.13 Q2 '22: -0.17 Q3 '22: -0.18 Q4 '22: -0.20 Q1 '23: -0.19 Q2 '23: -0.17 Q3 '23: -0.17 Q4 '23: -0.29 Q1 '24: -0.20 Q2 '24: -0.13 Q3 '24: -0.07 Q4 '24: -0.14 Q1 '25: -0.21 Q2 '25: -0.23 Q3 '25: -0.24 Q4 '25: -0.12 Q1 '26: -0.11 Q2 '26: -0.10 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.